Диссертация (Дифференциальная диагностика гигантоклеточных поражений костей у детей), страница 30
Описание файла
Файл "Диссертация" внутри архива находится в папке "Дифференциальная диагностика гигантоклеточных поражений костей у детей". PDF-файл из архива "Дифференциальная диагностика гигантоклеточных поражений костей у детей", который расположен в категории "". Всё это находится в предмете "медицина" из Аспирантура и докторантура, которые можно найти в файловом архиве РНИМУ им. Пирогова. Не смотря на прямую связь этого архива с РНИМУ им. Пирогова, его также можно найти и в других разделах. , а ещё этот архив представляет собой докторскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени доктора медицинских наук.
Просмотр PDF-файла онлайн
Текст 30 страницы из PDF
– 2012. – 32. – P.410-415.107.Katherine Wesseling, Sevcan Bakkaloglu, Isidro Salusky. Chronic kidneydisease mineral and bone disorder in children // Pediatr Nephrol. – 2008. –23. – P. 195–207. DOI 10.1007/s00467-007-0671-3.108.Thomas L. Pope, Hans L. Bloem, Javier Beltran, William B. Morrison,David J. Wilson. Musculoskeletal Imaging, 2nd edition. – 2015. – P. 924,933.109.Moskovszky L., Szuhai K., Krenacs T., Hogendoorn P.C., Szendroi M.,Benassi M.S., Kopper L., Fule T., Sapi Z. Genomic instability in giant celltumor of bone.
A study of 52 cases using DNA ploidy, relocalization FISH,and array-CGH analysis // Genes Cromosomes Cancer. – 2009 Jun. –48(6). – P. 468-79. DOI: 10.1002/gcc.20656.110.Brad W. Neville, Douglas D. Damm, Carl M. Allen, Angela C. Chi. Oraland Maxillofacial Pathology // Elsevier. – 2016. – P. 584-6.212111.Andrew P. Carlson, M.D., Howard Yonas, M.D., Garth T. Olson, M.D.,Kaaren K. Reichard, M.D., and Rafael Medina-Flores, M.D. TemporalChondroblastoma with a Novel Chromosomal Translocation (2;5)(q33;q13) // Skull Base Reports. – 2011. – VOL. 1. – № 1.
– P. 65-70.112.Tetsuro Yamagishi, Hiroyuki Kawashima, Akira Ogose, Takashi Ariizumi,Taro Sasaki, Hiroshi Hatano, Tetsuo Hotta, Naoto Endo. ReceptorActivator of Nuclear KappaB Ligand Expression as a New TherapeuticTarget in Primary Bone Tumors // PLOS ONE. – May 10, 2016. – P. 1/11 –11/11. DOI:10.1371/journal.pone.0154680.113.L Huang, Y Y Cheng, L T C Chow, M H Zheng, S M Kumta. Receptoractivator of NF-κB ligand (RANKL) is expressed in chondroblastoma:possible involvement in osteoclastic giant cell recruitment // J Clin Pathol:Mol Pathol. – 2003.
– 56. – P. 116–120.114.Sandip Barman, Preeti Diwaker, Divya Bansal, Neelam Wadhwa,Gurvinder Singh. Aneurysmal Bone Cyst: An Uncommon Secondary Eventin Calcaneal Chondroblastoma // Journal of Clinical and DiagnosticResearch.–2016Jun.–Vol-10(6).–P.14-16.DOI:10.7860/JCDR/2016/19524.8016.115.Stéphane Cherix, Yann Bildé, Fabio Becce, Igor Letovanec, and Hannes ARüdiger.Multiple non-ossifying fibromas as a cause of pathologicalfemoral fracture in Jaffe-Campanacci syndrome // BMC MusculoskeletalDisorders. – 2014. – 15. – P. 218.116.Adel K.
El-Naggar, John K.C. Chan, Jannifer R. Grandis, Takashi Takata,Pieter J. Slootweg. WHO Classification of Head and Neck Tumours //Lyon. – 2017. – P. 257-8.117.Prashant Narhari, Amber Haseeb, and Vivek Ajit Singh. SpontaneousConventional Osteosarcoma Transformation of a Chondroblastoma: A CaseReport and Literature Review // Indian J Orthop.
– 2018, Jan-Feb. – 52(1).– P.82-90.213118.Mohamed Ahmed Mashhour, Mohamed Abdel Rahman. Lower recurrencerate in chondroblastoma using extended curettage and cryosurgery //International Orthopaedics (SICOT). – 2014. – 38. – P. 1019–1024. DOI10.1007/s00264-013-2178-9.119.Jury Brandolini, Luca Bertolaccini, Alessandro Pardolesi, Maurizio Salvi,Mirca Valli, Piergiorgio Solli. Chondroblastoma of the rib in a 47-year-oldman: a case report with a systematic review of literature // Journal ofThoracicDisease.–2017.–9(10).–P.907-911.DOI:10.21037/jtd.2017.08.137.120.Yan Xiong, Yun Lang, Zeping Yu, Hongyuan Liu, Xiang Fang, ChongqiTu and Hong Duan.
The effects of surgical treatment with chondroblastomain children and adolescents in open epiphyseal plate of long bones. Xionget al // World Journ al of Surgical Oncology. – 2018. – 16. – P. 14. DOI10.1186/s12957-018-1314-9.121.Fernanda Amary, MD, PhD, Fitim Berisha, MSc, Hongtao Ye, PhD, ManuGupta, PhD, Alice Gutteridge, MSc, Daniel Baumhoer, MD, PhD, RebeccaGibbons, BSc, Roberto Tirabosco, MD, Paul O’Donnell, MD, andAdrienne M.
Flanagan, MD, PhD. H3F3A (Histone 3.3) G34WImmunohistochemistry. A Reliable Marker Defining Benign and MalignantGiant Cell Tumor of Bone // Am J Surg Pathol. – 2017. – P. 1-10.122.Svetoslav A. Slavchev, Georgi P. Georgiev, Kircho Patrikov. An ActiveGiant Cell Tumor of the Patella: A Case Report // A Case Report. Cureus. –2017. – 9(9).
– P.1642. DOI 10.7759/cureus.123.Andreas F. Mavrogenis, Vasileios G. Igoumenou, Panayiotis D.Megaloikonomos,GeorgiosN.Panagopoulos,PanayiotisJ.Papagelopoulos, and Panayotis N. Soucacos. Giant cell tumor of bonerevisited // SICOT J. – 2017. – 3. – P.
54.124.Kato Kaneko, M., Liu, X., Oki, H., Ogasawara, S., Nakamura, T., Saidoh,N., Kato, Y. Isocitrate dehydrogenase mutation is frequently observed in214giant cell tumor of bone // Cancer Science. – 2014. – 105(6). – P. 744–748.http://doi.org/10.1111/cas.12413.125.Giuseppina Divisato, Federica Scotto di Carlo, Laura Pazzaglia, RiccardoRizzo, Domenico A. Coviello, Maria Serena Benassi, Piero Picci, TeresaEsposito, and Fernando Gianfrancesco. The distinct clinical features ofgiant cell tumor of bone in pagetic and non-pagetic patients are associatedwith genetic, biochemical and histological differences // Oncotarget.
–2017. – Vol. 8. – No. 38. – P. 63121-63131.126.Mirra JM, Gold RH, Rand F: Disseminated nonossifying fibromas inassociation with cafe-au-lait spots (Jaffe-Campanacci syndrome) // ClinOrthop Relat Res. – 1982. – 168. – P. 192–205.127.Campanacci M, Laus M, Boriani S: Multiple non-ossifying fibromata withextraskeletal anomalies: a new syndrome? // J Bone Joint Surg Br. – 1983.– 65. – P. 627–632.128.Ammar C. Al-Rikabi, FRCPath, FIAC, Jyothi C. Ramaswamy, MBBS,MD, Venkatraman V.
Bhat, MD, FRCR. Jaffe-Campanacci syndrome.Case report // Saudi Med J. – 2005. – Vol. 26 (1). P. 104-106.129.Vipin Sharma, Seema Sharma, Kewal A. Mistry, Bhanu Awasthi, LuckyVerma, Uttam Singh. Giant cell tumor of bone in skeletally immaturepatients – a clinical perspective // Journal of Orthopaedic Case Reports.
–2015 Oct-Dec. – 5(4). – P. 57-60. DOI: 2250-0685.347.130.Nawal Hammas, Chbani Laila, Alaoui Lamrani My Youssef, El FatemiHind, Taoufiq Harmouch, Tizniti Siham, Amarti Afaf. Can p63 serve as abiomarker for giant cell tumor of bone? A Moroccan experience. Hammaset al // Diagnostic Pathology. – 2012. – 7. – P.130.131.Junling Liu1,2, Han Yang1,3, Rui Sun1,4, Zhijun Yang1,2, Zhihua Zhu.Retrospective analysis of patients with rare-site and metastatic giant celltumor // Chin J Cancer Res. – 2013.
– 25(5). – P. 585-592.132.Chenglei Liu, Yawen Tang, Mei Li, Qiong Jiao, Huizhen Zhang,Qingcheng Yang, Weiwu Yao. Clinical characteristics and prognoses of six215patients with multicentric giant cell tumor of the bone // Oncotarget. –2016. – Vol. 7. – No. 50. – P. 83795-83805.133.Arun S Singh, Neal S Chawla, Sant P Chawla. Giant-cell tumor of bone:treatment options and role of denosumab // Biologics: Targets and Therapy.– 2015. – 9. – P. 69–74. dx.doi.org/10.2147/BTT.S57359.134.Som. P. Gupta, Gaurav Garg.
Curettage with cement augmentation of largebone defects in giant cell tumors with pathological fractures in lowerextremity long bones // J Orthopaed Traumatol. – 2016. – 17. – P. 239–247. DOI 10.1007/s10195-016-0397-8.135.Pan Hu, Liming Zhao, Huilin Zhang, Xiuchun Yu, Zhen Wang, ZhaomingYe, Sujia Wu, Shibing Guo, Guochuan Zhang, Jinghua Wang, XianjiaNing, Yongcheng Hu, Yingze Zhang.
Recurrence Rates and Risk Factorsfor Primary Giant Cell Tumors around the Knee: A MulticentreRetrospective Study in China // Scientific Reports. –6:36332 | DOI:10.1038/srep36332.136.Federica Scotto di Carlo, Giuseppina Divisato, Maurizio Iacoangeli, TeresaEsposito, Fernando Gianfrancesco. The identification of H3F3A mutationin giant cell tumour of the clivus and the histological diagnostic algorithmof other clival lesions permit the differential diagnosis in this location.Scotto di Carlo et al // BMC Cancer.
– 2018. – 18. – P. 358.DOI.org/10.1186/s12885-018-4291-z.137.Judy Sarungbam, Narasimhan Agaram, Sinchun Hwang, Chao Lu, LuWang, John Healey, Meera Hameed. Symplastic/pseudoanaplastic giantcell tumor of the bone // Skeletal Radiol. – 2016 July. – 45(7). – P. 929–935. DOI:10.1007/s00256-016-2373-z.138.Hongbin Cao, Fengsong Lin, Yongcheng Hu, Liming Zhao, Xiuchun Yu,Zhen Wang, Zhaoming Ye, Sujia Wu, Shibing Guo, Guochuan Zhang,Jinghua Wang.
Epidemiological and Clinical Features of Primary GiantCell Tumors of the Distal Radium: A Multicenter Retrospective Study inChina // Scientific Reports. – 7: 9067. DOI:10.1038/s41598-017-09486-6.216139.Julian Luke, Alexandra von Baer, Jordan Schreiber, Christoph Lubbehusen,Thomas Breining, Kevin Mellert, Ralf Marienfeld, Markus Schultheiss,Peter Moller, Thomas F E Barth. H3F3A mutation in giant cell tumor of thebone is detected by immunohistochemistry using a monoclonal antibodyagainst the G34W mutated site of the histone H3.3 variant //Histopathology. – 2017. – 71. – P. 125-133.
DOI: 10.1111/his.13190.140.Cleven AH, Hocker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM,Bovee JV. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Toolfor Giant Cell Tumor of Bone and Chondroblastoma // Am J Surg Pathol. –2015 Nov. – 39(11).
– P. 1576-83. DOI: 10.1097/PAS.0000000000000512.141.Douglas R. Stewart, MD, Hilde Brems, PhD, Alicia G. Gomes, MS, CGC,Sarah L. Ruppert, MS, CGC, Tom Callens, BSc, Jennifer Williams, MS,Kathleen Claes, PhD, Michael B. Bober, MD, PhD, Rachel Hachen, MD,MPH, Leonard B. Kaban, MD, DDS, Hua Li, PhD, Angela Lin, MD, MarieMcDonald, MD, MBBCh, Serge Melancon, MD, June Ortenberg, MDCM,FRCPC, Heather B. Radtke, MS, CGC, Ignace Samson, MD, Robert A.Saul, MD, Joseph Shen, MD, PhD, Elizabeth Siqveland, RN, CNP, TomiL.
Toler, MS, CGC, Merel van Maarle, MD, PhD, Margaret Wallace, PhD,Misti Williams, PhD, Eric Legius, MD, PhD, and Ludwine Messiaen, PhD.Jaffe–Campanacci syndrome, revisited: detailed clinical and molecularanalyses determine whether patients have neurofibromatosis type 1,coincidental manifestations, or a distinct disorder // GeNeTICs inMeDICINe. – June 2014. – Vol. 16. – Num. 6. – P. 448-59..
